Notably, we observed higher CUL4B expression among those who responded positively to immunotherapy. These findings underscore the significance of CUL4B in the resistance to cisplatin in lung cancer, highlighting its potential as a therapeutic target.
2 years ago
Journal • IO biomarker • Epigenetic controller
|
CD8 (cluster of differentiation 8) • CUL4B (Cullin 4B)